NCT03685539: DECT in Imaging Patients With Solid Organ Cancer With Intracranial Metastasis

NCT03685539
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: Patients must have planned treatment with stereotactic radiosurgery
Exclusions: Patients with prior central nervous system malignancy or prior brain radiation
https://ClinicalTrials.gov/show/NCT03685539

Comments are closed.

Up ↑